Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sarcomatoid renal carcinoma]

J M Martinez Jabaloyas1, J L Ruiz Cerdá, S Sanz Chinesta

  • 1Servicio de Urología, Hospital Universitario La Fe, Valencia.

Actas Urologicas Espanolas
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgery or radiotherapy: Determining factors in therapeutic decision-making for localized prostate cancer in Spain.

Actas urologicas espanolas·2026
Same author

Impact of aging on the incidence and mortality of urological cancers: 20-year projection in Spain.

Actas urologicas espanolas·2022
Same author

In vivo aneuploidization during the expansion of renal adenocarcinoma.

Urologia internationalis·2011
Same author

[Watchful waiting in incidental adenocarcinoma of the prostate].

Actas urologicas espanolas·2010
Same author

[Ureteral reimplantation and gestational acute renal failure: a case report].

Actas urologicas espanolas·2010
Same author

[Analysis of overactive bladder and urinary incontinence in males in the age range between 50 and 65 years. EPICC study].

Actas urologicas espanolas·2010
Same journal

Comparative outcomes of Mini-PCNL and suction-assisted flexible ureteroscopy in patients with renal stones ≥2 cm.

Actas urologicas espanolas·2026
Same journal

Morphometric changes in pelvic floor structure following non-invasive rehabilitation and neuromodulation assessed by ultrasound imaging.

Actas urologicas espanolas·2026
Same journal

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same journal

i-PCNL: a novel ureteral-catheter application for continuous unidirectional high-flow irrigation during Percutaneous Nephrolithotomy. Technique description and preliminary outcomes.

Actas urologicas espanolas·2026
Same journal

Reconstructing the reconstructed: Outcomes of redo-urethroplasty for recurrent urethral strictures.

Actas urologicas espanolas·2026
Same journal

Functional outcomes of pyeloplasty in children with reduced preoperative renal function: A multicenter study.

Actas urologicas espanolas·2026
See all related articles

Sarcomatoid renal cell carcinoma, a rare variant, shows poor prognosis with a median survival of 6 months. Early-stage tumors confined within the renal capsule demonstrated no disease progression, highlighting the importance of surgical staging for sarcomatoid renal tumors.

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Context:

  • Renal cell carcinoma (RCC) encompasses various histological subtypes.
  • The sarcomatoid variant of RCC is recognized for its aggressive behavior and poor prognosis.
  • Understanding prognostic factors in sarcomatoid RCC is crucial for patient management.

Purpose:

  • To investigate the clinicopathological features and outcomes of sarcomatoid renal cell carcinoma.
  • To evaluate the prognostic significance of tumor stage, DNA content, and nuclear morphometry in sarcomatoid RCC.
  • To compare survival rates between sarcomatoid RCC and other histological patterns of renal carcinoma.

Summary:

  • A study of 250 nephrectomies identified 10 cases (4%) of sarcomatoid RCC.
  • Only 2 cases, confined within the renal capsule, showed no disease progression post-surgery.

Related Experiment Videos

  • Median survival for sarcomatoid RCC was 6 months, significantly lower than other subtypes.
  • Diploid DNA content and specific nuclear perimeter measurements correlated with non-progressive disease.

    • Impact:

    • Identifies early tumor encapsulation as a key factor for favorable outcomes in sarcomatoid RCC.
    • Highlights the prognostic value of flow cytometry (DNA content) and nuclear morphometry in predicting disease progression.
    • Provides evidence for the distinct aggressive nature and poorer survival associated with the sarcomatoid histological variant of renal carcinoma.